The effect of TC14012 on alkali burn-induced corneal neovascularization in mice

Ophthalmic Research

Volumn 52, Issue 1, 2014, Pages 17-24

  Shen, Minqian ^a   Yuan, Fei ^a   Jin, Jing ^a   Yuan, Yuanzhi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Alkali burn; Corneal neovascularization; CXCR7; TC14012

Indexed keywords

ALKALI; BETA ARRESTIN 2; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR7; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TC 14012; UNCLASSIFIED DRUG; VASCULOTROPIN; CHEMOKINE RECEPTOR CXCR; CMKOR1 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; OLIGOPEPTIDE; SODIUM HYDROXIDE; TC14012; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; BETA ARRESTIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG EFFECT; ENZYME ACTIVATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BURNS, CHEMICAL; CHEMICALLY INDUCED; CONJUNCTIVA; CORNEAL NEOVASCULARIZATION; DISEASE MODEL; DRUG EFFECTS; EYE BURN; GENE EXPRESSION REGULATION; GENETICS; INTRAOCULAR DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; CAUSTIC BURN; ENZYME PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BURNS, CHEMICAL; CONJUNCTIVA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; EYE BURNS; GENE EXPRESSION REGULATION; INJECTIONS, INTRAOCULAR; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR; RECEPTORS, CXCR4; RNA, MESSENGER; SODIUM HYDROXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84900887409     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000358201     Document Type: Article

References (32)

1. Chang JH, Gabison EE, Kato T, Azar DT: Corneal neovascularization. Curr Opin Ophthalmol 2001; 12: 242-249.
2. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, Napolitano M: Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003; 273: 83-101.
3. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP: CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 593-609.
4. Maksym RB, Tarnowski M, Grymula K, Tarnowska J, Wysoczynski M, Liu R, Czerny B, Ratajczak J, Kucia M, Ratajczak MZ: The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol 2009; 625: 31-40.
5. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766.
6. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213.
7. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, Lefkowitz RJ: Beta-arrestin-but not G protein-mediated signaling by the 'decoy' receptor CXCR7. Proc Natl Acad Sci USA 2010; 107: 628-632.
8. Hernandez L, Magalhaes MA, Coniglio SJ, Condeelis JS, Segall JE: Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res 2011; 13:R128.
9. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735-15740.
10. Peng LH, Shen W, Yong W, Lu L, Liu L: Effects of AMD3100 subconjunctival injection on alkali burn induced corneal neovascularization in mice. Int J Ophthalmol 2011; 4: 44-48.
11. Proia AD, Chandler DB, Haynes WL, Smith CF, Suvarnamani C, Erkel FH, Klintworth GK: Quantitation of corneal neovascularization using computerized image analysis. Lab Invest 1988; 58: 473-479.
12. Gravel S, Malouf C, Boulais PE, Berchiche YA, Oishi S, Fujii N, Leduc R, Sinnett D, Heveker N: The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. J Biol Chem 2010; 285: 37939-37943.
13. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N: AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 2009; 75: 1240-1247.
14. Tamamura H, Omagari A, Hiramatsu K, Gotoh K, Kanamoto T, Xu Y, Kodama E, Matsuoka M, Hattori T, Yamamoto N, Nakashima H, Otaka A, Fujii N: Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. Bioorg Med Chem Lett 2001; 11: 1897-1902.
15. Xu QY, Yuan YZ, Wang LY, Yuan F: Antiangiogenesis effect of AMD3100 in oxygeninduced retinopathy mice (in Chinese). Zhonghua Yan Ke Za Zhi/Chinese J Ophthalmol 2012; 48: 350-355.
16. Epstein RJ, Stulting RD: Corneal neovascularization induced by stimulated lymphocytes in inbred mice. Invest Ophthalmol Vis Sci 1987; 28: 1505-1513.
17. Costello CM, McCullagh B, Howell K, Sands M, Belperio JA, Keane MP, Gaine S, McLoughlin P: A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease. Eur Respir J 2012; 39: 1415-1424.
18. Gerrits H, van Ingen Schenau DS, Bakker NE, van Disseldorp AJ, Strik A, Hermens LS, Koenen TB, Krajnc-Franken MA, Gossen JA: Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 2008; 46: 235-245.
19. Wang J, Shiozawa Y, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294.
20. Haege S, Einer C, Thiele S, Mueller W, Nietzsche S, Lupp A, Mackay F, Schulz S, Stumm R: CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney. PloS One 2012; 7:e42814.
21. Lee E, Han J, Kim K, Choi H, Cho EG, Lee TR: CXCR7 mediates SDF1-induced melanocyte migration. Pigment Cell Melanoma Res 2013; 26: 58-66.
22. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M: CXCR7 functions as a scavenger for CXCL12 and CXCL11. PloS One 2010; 5:e9175.
23. Decaillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, Sachdev P: CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem 2011; 286: 32188-32197.
24. Heinrich EL, Lee W, Lu J, Lowy AM, Kim J: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med 2012; 10: 68.
25. Liberman J, Sartelet H, Flahaut M, Muhlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM, Gross N: Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma. PloS One 2012; 7:e43665.
26. Yan X, Cai S, Xiong X, Sun W, Dai X, Chen S, Ye Q, Song Z, Jiang Q, Xu Z: Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation. J Cell Biochem 2012; 113: 1437-1446.
27. Watanabe K, Penfold ME, Matsuda A, Ohyanagi N, Kaneko K, Miyabe Y, Matsumoto K, Schall TJ, Miyasaka N, Nanki T: Pathogenic role of CXCR7 in rheumatoid arthritis. Arthr Rheum 2010; 62: 3211-3220.
28. Canals M, Scholten DJ, de Munnik S, Han MK, Smit MJ, Leurs R: Ubiquitination of CXCR7 controls receptor trafficking. PloS One 2012; 7:e34192.
29. Uto-Konomi A, McKibben B, Wirtz J, Sato Y, Takano A, Nanki T, Suzuki S: CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4. Bioch Biophys Res Commun 2013; 431: 772-776.
30. Kim HY, Hwang JY, Oh YS, Kim SW, Lee HJ, Yun HJ, Kim S, Yang YJ, Jo DY: Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro. Korean J Hematol 2011; 46: 244-252.
31. Kumar P, Lau CS, Mathur M, Wang P, DeFea KA: Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2. Am J Physiol Cell Physiol 2007; 293:C346-C357.
32. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD: Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010; 29: 4599-4610.